The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, ClearPoint Neuro's share price is $5.26.
ClearPoint Neuro's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.97. Hence, ClearPoint Neuro's PS Ratio for today is 5.40.
Good Sign:
ClearPoint Neuro Inc stock PS Ratio (=5.45) is close to 3-year low of 4.91
The historical rank and industry rank for ClearPoint Neuro's PS Ratio or its related term are showing as below:
CLPT'
s PS Ratio Range Over the Past 10 Years
Min: 0.84 Med: 7.45 Max: 35.88
Current: 5.59
During the past 13 years, ClearPoint Neuro's highest PS Ratio was 35.88. The lowest was 0.84. And the median was 7.45.
CLPT's PS Ratio is ranked worse than 68.28% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 3.19
vs CLPT: 5.59
During the past 12 months, the average Revenue per Share Growth Rate of ClearPoint Neuro was 14.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 6.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 5.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -12.60% per year.
During the past 13 years, ClearPoint Neuro's highest 3-Year average Revenue per Share Growth Rate was 6.40% per year. The lowest was -36.50% per year. And the median was -21.40% per year.
Back to Basics: PS Ratio
ClearPoint Neuro PS Ratio Historical Data
The historical data trend for ClearPoint Neuro's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ClearPoint Neuro's PS Ratio
For the Medical Devices subindustry, ClearPoint Neuro's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ClearPoint Neuro's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's PS Ratio distribution charts can be found below:
* The bar in red indicates where ClearPoint Neuro's PS Ratio falls into.
ClearPoint Neuro PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
ClearPoint Neuro's Share Price of today is $5.26. ClearPoint Neuro's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.97.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
ClearPoint Neuro PS Ratio Related Terms
Thank you for viewing the detailed overview of ClearPoint Neuro's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
ClearPoint Neuro (ClearPoint Neuro) Business Description
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace is used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint neuro system, MRI-guided drug delivery, and Thermal therapy system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLPT has been successfully added to your 